Showing results (1921-1930 of 3,794) with videos related to

Sort By:
Pageof 380
Oncoimmunology|April 9, 2016
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunityYongkui Li, Min Fang, Jian Zhang, et al.
Oncoimmunology|April 9, 2016
Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferationAngela Maselli, Sara Capoccia, Patrizia Pugliese, et al.
Oncoimmunology|April 9, 2016
A century of oncolysis evolves into oncolytic immunotherapyO Hemminki, A Hemminki
Oncoimmunology|April 9, 2016
Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptorsAndrea Acebes-Huerta, Seila Lorenzo-Herrero, Alicia R Folgueras, et al.
Oncoimmunology|April 9, 2016
PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in Invasive breast cancerHonggeng Guan, Yang Lan, Yuqiu Wan, et al.
Oncoimmunology|April 9, 2016
Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancerChristine Mall, Gail D Sckisel, David A Proia, et al.
Oncoimmunology|April 9, 2016
Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patientsAfsar Rahbar, Madeleine Cederarv, Nina Wolmer-Solberg, et al.
Oncoimmunology|April 9, 2016
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironmentLaetitia Fend, Christelle Remy-Ziller, Johann Foloppe, et al.
Oncoimmunology|April 9, 2016
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade gliomaLien Vandenberk, Abhishek D Garg, Tina Verschuere, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
Pageof 380